Avant Technologies Proposes Acquisition of Ainnova Tech to Consolidate Vision AI JV
May 13, 2025
Avant Technologies has entered formal negotiations to acquire its joint-venture partner Ainnova Tech (operating through Ai-nova Acquisition Corp.), aiming to merge the businesses ahead of an FDA pre-submission meeting. The deal is intended to streamline regulatory coordination, speed clinical development and support U.S. market entry for the Vision AI clinical screening platform currently piloted across Latin America.
- Buyers
- Avant Technologies, Inc., Ai-nova Acquisition Corp. (AAC)
- Targets
- Ainnova Tech
- Industry
- Healthcare Services
- Location
- Texas, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Voiant Acquires Voxeleron
August 2, 2025
AI & Machine Learning
Voiant has acquired Voxeleron, an AI-driven ophthalmic image analysis company, to integrate advanced AI/ML imaging capabilities into its clinical trial imaging platform. The deal combines Voiant’s clinical trial imaging expertise with Voxeleron’s cloud-based image analysis tools to accelerate biomarker development, improve data accuracy, and enhance ophthalmology-focused clinical research services.
-
Vantaca Acquires HOAi
November 20, 2024
Software
Vantaca, the community association management software provider, has acquired HOAi, an AI technology company focused on HOA management, to integrate advanced AI capabilities into its platform. HOAi will continue to operate as an independent product while its AI technology is integrated with Vantaca to accelerate product development and enhance operational efficiency for community managers and boards.
-
Capital A Acquires Majority Stake in ARVOO Imaging Products
October 20, 2023
AI & Machine Learning
Capital A (Capital A Investment Partners) has acquired a majority stake in ARVOO Imaging Products to fund the company’s next growth phase and support international expansion. ARVOO’s management (CEO Fons Grijpink and CTO René Voorwinden) remain in operational control while Capital A will act as a sponsor to accelerate globalization and pursue a selective buy-and-build strategy.
-
Vaccitech plc Acquires Avidea Technologies to Expand SNAPvax Pipeline
December 13, 2021
Biotechnology
Vaccitech plc acquired US-based Avidea Technologies, Inc. for approximately $40 million (about $12.5M cash and $27.5M in Vaccitech ADS) plus potential milestone payments. The deal brings Avidea's SNAPvax™ nanoparticle platform and early-stage product candidates into Vaccitech's pipeline, expands Vaccitech's U.S. R&D presence, and adds Avidea co-founders to Vaccitech's scientific team.
-
Novo Integrated Sciences / Novo Healthnet Acquire Acenzia Inc.
June 29, 2021
Pharmaceuticals
Novo Integrated Sciences, through its wholly owned subsidiary Novo Healthnet Limited, completed the acquisition of Acenzia Inc., a Windsor, Ontario-based nutraceutical manufacturer and diagnostics developer. The all-share transaction closed on June 24, 2021 and is valued at $14,884,039; Novo said the purchase will give it direct control of development, manufacturing and distribution of wellness products and personalized diagnostics.
-
Advanced Integration Technology Acquires Nova-Tech Engineering
December 22, 2016
Aerospace & Defense
Advanced Integration Technology (AIT) announced an investment to acquire Nova-Tech Engineering, a Lynnwood, Washington-based designer and integrator of aerospace assembly automation, materials handling and friction-stir welding equipment. Nova-Tech will operate as a distinct business line within AIT, expanding AIT’s aerospace automation capabilities and international footprint; financial terms were not disclosed.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.